id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OAR-2006-0159-0060,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007,Rule,Federal Register Document,2007-06-12T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,E7-11319,0,0,090000648024eb61
EPA-HQ-OAR-2006-0159-0061,EPA,EPA-HQ-OAR-2006-0159,2007 Final Rule Submitted to OMB (Office of Management and Budget),Supporting & Related Material,Federal Register Document,2007-06-12T04:00:00Z,2007,6,,,2011-06-11T16:02:05Z,,0,0,090000648024e9f4
EPA-HQ-OAR-2006-0159-0051,EPA,EPA-HQ-OAR-2006-0159,Second Letter to USEPA from the US Stakeholder Group on MDI Transition,Supporting & Related Material,"Letter, Memorandum, Email",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:46Z,,0,0,090000648023dfc1
EPA-HQ-OAR-2006-0159-0059,EPA,EPA-HQ-OAR-2006-0159,FDA (Food and Drug Administration) Rulemaking: Use of Ozone-Depleting Substances; Removal of Essential-Use Designations (70 FR 17168),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:04Z,,0,0,0900006480249f74
EPA-HQ-OAR-2006-0159-0056,EPA,EPA-HQ-OAR-2006-0159,Decision XII/2 from the 12th Meeting of the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:56Z,,0,0,0900006480249f5f
EPA-HQ-OAR-2006-0159-0050,EPA,EPA-HQ-OAR-2006-0159,Letter to USEPA from the US Stakeholders Group on MDI Transition,Supporting & Related Material,"Letter, Memorandum, Email",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:44Z,,0,0,090000648023dfb7
EPA-HQ-OAR-2006-0159-0053,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential-Use Allowances for Calendar Year 2002; and Extension of the De Minimis Exemption for Essential Laboratory and Analytical Uses Through Calendar Year 2005; Final Rule (67 FR 6352),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,,0,0,0900006480249f4b
EPA-HQ-OAR-2006-0159-0055,EPA,EPA-HQ-OAR-2006-0159,Decision XVIII/7 from the 18th Meeting of the Parties to the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:54Z,,0,0,0900006480249f5a
EPA-HQ-OAR-2006-0159-0058,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone; Extension of Global Laboratory and Analytical Use Exemption for Essential Class I Ozone Depleting Substances (70 FR 77048),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,,0,0,0900006480249f71
EPA-HQ-OAR-2006-0159-0057,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2005; Final Rule (70 FR 49836),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,,0,0,0900006480249f68
EPA-HQ-OAR-2006-0159-0049,EPA,EPA-HQ-OAR-2006-0159,Schering-Plough Letter to U.S. Government Stakeholders,Supporting & Related Material,"Letter, Memorandum, Email",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:43Z,,0,0,090000648023dfa9
EPA-HQ-OAR-2006-0159-0052,EPA,EPA-HQ-OAR-2006-0159,Decision VIII/10 from the 8th Meeting of the Parties to the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:47Z,,0,0,0900006480249f47
EPA-HQ-OAR-2006-0159-0054,EPA,EPA-HQ-OAR-2006-0159,Decision XVII/5 from the 17th Meeting of the Parties to the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:52Z,,0,0,0900006480249f56
EPA-HQ-OAR-2006-0159-0044,EPA,EPA-HQ-OAR-2006-0159,"2007 Food and Drug Administration (FDA) Determination Letter (Revised, May 4, 2007)",Supporting & Related Material,"Letter, Memorandum, Email",2007-05-31T04:00:00Z,2007,5,,,2007-05-31T14:43:58Z,,0,0,090000648024599b
EPA-HQ-OAR-2006-0159-0043,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for CONFIDENTIAL supplementary information received by EPA from Robert M. Sussman of Latham and Watkins, LLC, council for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on February 22, 2007",Supporting & Related Material,Other,2007-02-27T05:00:00Z,2007,2,,,2007-02-27T18:26:42Z,,0,0,090000648020bd6b